Please note that this content was created in 2018. In the time since this material was posted, there may have been additional developments, advancements, and/or more current publications in this field.
AMP Education is constantly updating our educational offerings, and will remove or replace content that is no longer accurate. Please be sure to use the search function to find related or updated material available in our catalogue at educate.amp.org. The Training and Education Committee works with AMP Education Programs to bring you the most up-to-date and cutting-edge information on molecular pathology research, applications, and training.
This is a recording of a session from the AMP 2018 Annual Meeting & Expo. Purchase the entire AMP 2018 Annual Meeting & Expo Recordings for a significant discount!
We will discuss the recent advances in the genomic characterization of pediatric AML and MDS. In particular, we will discuss the differences observed between these diseases in children and adults and how some subtypes of AML/MDS are enriched in different age groups. A commentary on how these pediatric lesions can be used to detect minimal residual disease or guide therapy will be included. Lastly, we will discuss recent work on different germline lesions found in pediatric AML and MDS.
Genomics of Pediatric AML and MDS
Jeffery Klco, MD, PhD, St Jude Children's Research Hospital, Memphis, TN, USA
Objectives:
- Summarize the genomic differences between pediatric and adult AML.
- Discuss the development of MDS in children.
- Compare different MRD approaches in children with AML.
Duration: 1.00 hr
Recording Date: November 1, 2018
Last day to purchase: December 31, 2021
Note: Join the AMP Family for discounted access to the most current educational resources!
All sales are final. No refunds will be issued.
No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.
